TUESDAY, SEPTEMBER 27, 2016

Vaxart to present at Euro Global Summit on Vaccines

Vaxart presentation at 6th Euro Global Summit and Expo on Vaccines and Vaccination | Courtesy of medicalexpo.com
Vaxart Inc., a clinical-stage, privately held company that creates vaccines for delivery to patients through tablets instead of injections, recently announced that it will give a presentation at the sixth Euro Global Summit and Expo on Vaccines and Vaccination.

Vaxart's Associate Director of Immunology Wendy Peters will give a presentation titled “A Non-Replicating Ad5 Vaccine for the Treatment of HSV-2 Infection.” The Tuesday presentation is about the preclinical data from the company’s HSV-2 therapeutic vaccine.

Vaxart uses its proprietary oral recombinant vaccines platform to make medical innovations. Patients receive Vaxart vaccines through tablets that are convenient and stable at room temperature and can be stored and shipped without the bulky equipment for refrigeration. They decrease the risk of needle-stick injuries, are easy to administer, and decrease the waste of medical resources.

The event is being hosted in Birmingham, U.K., at the Hilton Birmingham Metropole Hotel National Exhibition Centre.

Organizations in this story

Vaxart Inc. 385 Oyster Point Blvd South San Francisco, CA 94080

Hilton Birmingham Metropole Hotel Birmingham, West Midlands B40 1NT, United Kingdom ,

Get notified the next time we write about any of these organizations!